Immune induction strategies to enhance responses to PD-1 blockade: lessons from the TONIC trial

Programmed cell death protein 1 (PD-1) blockade is only effective in a minority of patients, prompting the search for combinatorial therapies that increase responses. Identifying effective combinations requires lengthy testing and so far has shown few successes. To accelerate progress Voorwerk and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Demaria, Sandra, Romano, Emanuela, Brackstone, Muriel, Formenti, Silvia C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868725/
https://www.ncbi.nlm.nih.gov/pubmed/31752991
http://dx.doi.org/10.1186/s40425-019-0783-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868725/
https://www.ncbi.nlm.nih.gov/pubmed/31752991
http://dx.doi.org/10.1186/s40425-019-0783-x

Ejemplares similares